Thermo Fisher Scientific Excelsior ES Selected by Robert Jones and Agnes Hunt Histopathology Laboratory to Accelerate Processing Times
Runcorn, Cheshire. (February 12 2010) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced that The Robert Jones and Agnes Hunt Orthopaedic and District Hospital (RJAH), the UK's leading orthopedic hospital, has chosen the Thermo Scientific Excelsior ES tissue processor for the preparation of samples in its histopathology laboratory. The Excelsior(TM) ES has set new standards for the efficiency of tissue processing at the facility, significantly reducing turnaround times by 38 percent for bone specimens, from 52 hours to 32.5 hours. In addition, the advanced reagent management system incorporated into the new instrument brings objectivity to the rotation of reagents, which further enhances reproducibility of processing.
The histopathology lab at RJAH plays a significant role in the hospital's Bone Tumor Service, one of only five specialist sites in the UK approved for the diagnosis and surgical management of bone tumors. Prior to installing the Excelsior ES, the laboratory had been experiencing challenges with its tissue processing equipment, with the time being attributed to the preparation of samples for analysis being of particular concern. According to RJAH, one of the primary deciding factors in choosing the Excelsior ES was the instrument's capability to meet the laboratory's most demanding tissue processing applications. For RJAH, incorporation of the new processor into the laboratory has provided a safe, reliable instrument which offers consistent results, particularly for its bone samples.
In addition to reducing the overall turnaround time for sample processing, the implementation of the Excelsior ES at RJAH has also improved the quality of the sample processing itself. In the past, the shrinkage of marrow/soft tissues from bony structures was commonly seen in the laboratory. By upgrading to the new instrumentation, the team at RJAH has noticed a marked reduction in its incidence. The Excelsior ES has also provided RJAH's histopathology department with the benefits of ease-of-use, improved maintenance of morphological integrity and reagent cost savings.
Nigel Harness, manager of the Histopathology Lab at RJAH, says: "The Thermo Scientific Excelsior ES was selected for its excellent efficiency and ability to meet our most demanding tissue processing applications. The implementation of the instrument has considerably enhanced laboratory productivity and sample turnaround has been accelerated while ensuring optimum results. The impact of a 38 percent reduction in our processing time for bone samples means that diagnoses are achieved more quickly and patients can be treated faster."
For more information about the Thermo Scientific Excelsior ES, please call + 44 (0)800 018 9396, e-mail pathology@scottpr.com or visit http://www.thermo.com/pathology
Thermo Scientific is part of Thermo Fisher Scientific Inc.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 35,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
For further press information please contact:
Laura Browne,
The Scott Partnership,
1 Whiteside,
Station Road,
Holmes Chapel,
Cheshire CW4 8AA,
United Kingdom
Tel: + 44 1477 539539
Fax: +44 1477 539 540
E-mail: pathology@scottpr.com
Anatomical Pathology Division
Media Contact Information:
Name: Michelle Valentine
Phone: +44 1477 539539
Email: pathology@scottpr.com
Secondary Contact Information
Name: Markus Haas
Phone: +49 6227 836 437
Email: markus.haas@thermofisher.com
